Literature DB >> 21779201

Pathogen Reduction in Blood Products: What's Behind These Techniques?

Karin Janetzko1, Peter Bugert.   

Abstract

Year:  2011        PMID： 21779201      PMCID： PMC3132975          DOI： 10.1159/000324457

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  15 in total

Review 1.  Population biology of emerging and re-emerging pathogens.

Authors:  Mark E J Woolhouse
Journal:  Trends Microbiol       Date:  2002       Impact factor: 17.079

Review 2.  Emerging infectious threats to the blood supply.

Authors:  Roger Y Dodd; David A Leiby
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

3.  UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.

Authors:  Axel Seltsam; Thomas H Müller
Journal:  Transfus Med Hemother       Date:  2011-01-22       Impact factor: 3.747

4.  Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™

Authors:  Johannes Irsch; Lily Lin
Journal:  Transfus Med Hemother       Date:  2011-01-27       Impact factor: 3.747

5.  The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma.

Authors:  Peter Hellstern; Bjarte G Solheim
Journal:  Transfus Med Hemother       Date:  2011-01-17       Impact factor: 3.747

6.  A comparison of three rapid bacterial detection methods under simulated real-life conditions.

Authors:  Michael Schmidt; Michael K Hourfar; Sven-Boris Nicol; Alexandra Wahl; Julia Heck; Christina Weis; Torsten Tonn; Hans-Peter Spengler; Thomas Montag; Erhard Seifried; W Kurt Roth
Journal:  Transfusion       Date:  2006-08       Impact factor: 3.157

7.  Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study.

Authors:  P Perez; L R Salmi; G Folléa; J L Schmit; B de Barbeyrac; P Sudre; R Salamon
Journal:  Transfusion       Date:  2001-07       Impact factor: 3.157

8.  Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.

Authors:  Jerard Seghatchian; Wilhelm G Struff; Stefan Reichenberg
Journal:  Transfus Med Hemother       Date:  2011-01-27       Impact factor: 3.747

9.  Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

Authors:  Susanne Marschner; Raymond Goodrich
Journal:  Transfus Med Hemother       Date:  2011-01-31       Impact factor: 3.747

10.  Transfusion-transmitted bacterial infection in the United States, 1998 through 2000.

Authors:  M J Kuehnert; V R Roth; N R Haley; K R Gregory; K V Elder; G B Schreiber; M J Arduino; S C Holt; L A Carson; S N Banerjee; W R Jarvis
Journal:  Transfusion       Date:  2001-12       Impact factor: 3.157
View more
  2 in total

Review 1.  Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.

Authors:  Karen Bieback
Journal:  Transfus Med Hemother       Date:  2013-08-26       Impact factor: 3.747

2.  Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.

Authors:  José Paulo Martins; Jorge Miguel Santos; Joana Marto de Almeida; Mariana Alves Filipe; Mariana Vargas Teixeira de Almeida; Sílvia Cristina Paiva Almeida; Ana Água-Doce; Alexandre Varela; Mari Gilljam; Birgitta Stellan; Susanne Pohl; Kurt Dittmar; Werner Lindenmaier; Evren Alici; Luís Graça; Pedro Estilita Cruz; Helder Joaquim Cruz; Rita Nogueira Bárcia
Journal:  Stem Cell Res Ther       Date:  2014-01-17       Impact factor: 6.832
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.